ArticleHistochemistry and cell biology2025
Mechanical-enzymatic isolation and characterization of primary human gingival epithelial cells for reproducible in vitro oral mucosa models.
Article in Histochemistry and cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- November in focus in HCB.Histochemistry and cell biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The establishment of reliable in vitro oral mucosa models is essential for advancing studies in epithelial barrier function, wound healing, and host-microbe interactions. However, the widespread use of immortalized cell lines such as HaCaT or TR146 limits physiological relevance owing to altered differentiation profiles and genetic drift. In this study, we developed a robust mechanical-enzymatic protocol for isolating and expanding primary human gingival keratinocytes from healthy gingival explants without feeder layers. The resulting cells demonstrated high viability, maintained consistent proliferative capacity across passages, and exhibited characteristic cobblestone morphology. Comprehensive phenotypic validation included immunofluorescence and immunohistochemistry confirming strong expression of epithelial markers CK18, AE1/AE3, and MUC1, with absence of the mesenchymal marker vimentin. Transcriptomic analysis using RT-qPCR corroborated epithelial lineage fidelity, revealing stable MUC1 expression and lack of MUC5AC transcripts, indicative of a nonglandular phenotype. Metabolic competence was supported by WST-1 assays that correlated strongly with manual cell counts, underscoring functional viability. Importantly, AGS and 293T/17 cell lines were processed in parallel as orthogonal controls to confirm assay specificity and lineage discrimination. Under rigorously standardized, within-laboratory conditions, our workflow yielded high interdonor concordance in epithelial identity and growth kinetics across a young-adult cohort (n = 3), supporting its use as a practical primary-cell platform for downstream applications. Generalizable reproducibility-across age strata, operators, and sites-will require formal, preregistered multicenter validation. By mitigating limitations inherent to immortalized lines, this approach enables more accurate investigations of epithelial biology and strengthens the reliability of in vitro experimental systems relevant to oral regenerative medicine and mucosal immunology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.